| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |